BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 33628581)

  • 1. Competing endogenous RNAs in lung cancer.
    Zhao M; Feng J; Tang L
    Cancer Biol Med; 2021 Feb; 18(1):1-20. PubMed ID: 33628581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competing Endogenous RNAs (ceRNAs) in Colorectal Cancer: A Review.
    Akhbari MH; Zafari Z; Sheykhhasan M
    Expert Rev Mol Med; 2022 Jun; 24():e27. PubMed ID: 35748050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of ncRNAs as ceRNAs in Gastric Cancer.
    Ye J; Li J; Zhao P
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational Identification of Cross-Talking ceRNAs.
    Li Y; Huo C; Lin X; Xu J
    Adv Exp Med Biol; 2018; 1094():97-108. PubMed ID: 30191491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competing endogenous RNAs and cancer: How coding and non-coding molecules cross-talk can impinge on disease.
    Ala U
    Int J Biochem Cell Biol; 2021 Jan; 130():105874. PubMed ID: 33227395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Dong R; Liu J; Sun W; Ping W
    Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
    Zhang L; Tao H; Li J; Zhang E; Liang H; Zhang B
    Aging (Albany NY); 2021 May; 13(12):15990-16008. PubMed ID: 34049287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer.
    Conte F; Fiscon G; Chiara M; Colombo T; Farina L; Paci P
    PLoS One; 2017; 12(2):e0171661. PubMed ID: 28187158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of hub lncRNA ceRNAs in multiple sclerosis based on ceRNA mechanisms.
    Ding Y; Li T; Yan X; Cui M; Wang C; Wang S; Zhang F; Zhang R
    Mol Genet Genomics; 2021 Mar; 296(2):423-435. PubMed ID: 33507382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular network-based identification of competing endogenous RNAs in bladder cancer.
    Jiang WD; Yuan PC
    PLoS One; 2019; 14(8):e0220118. PubMed ID: 31369587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
    Tan J; Wang W; Song B; Song Y; Meng Z
    Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
    Zhou RS; Zhang EX; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y
    BMC Cancer; 2019 Aug; 19(1):779. PubMed ID: 31391008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
    Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
    Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CLDN5 affects lncRNAs acting as ceRNA dynamics contributing to regulating blood‑brain barrier permeability in tumor brain metastasis.
    Ma SC; Li Q; Peng JY; Zhouwen JL; Zhang DN; Zhang CB; Jiang WG; Jia W
    Oncol Rep; 2018 Mar; 39(3):1441-1453. PubMed ID: 29328410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Building a Competing Endogenous RNA Network to Find Potential Long Non-Coding RNA Biomarkers for Pheochromocytoma.
    Liang YC; Wu YP; Chen DN; Chen SH; Li XD; Sun XL; Wei Y; Ning X; Xue XY
    Cell Physiol Biochem; 2018; 51(6):2916-2924. PubMed ID: 30562748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competing Endogenous RNAs (CeRNAs): Novel Network in Neurological Disorders.
    Tehrani SS; Ebrahimi R; Al-E-Ahmad A; Panahi G; Meshkani R; Younesi S; Saadat P; Parsian H
    Curr Med Chem; 2021; 28(29):5983-6010. PubMed ID: 33334276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
    Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
    Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
    Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The non-coding competing endogenous RNAs in acute myeloid leukemia: biological and clinical implications.
    Zhou Q; Shu X; Chai Y; Liu W; Li Z; Xi Y
    Biomed Pharmacother; 2023 Jul; 163():114807. PubMed ID: 37150037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Regulatory Network and Potential Role of LINC00973-miRNA-mRNA ceRNA in the Progression of Non-Small-Cell Lung Cancer.
    Guo Q; Li D; Luo X; Yuan Y; Li T; Liu H; Wang X
    Front Immunol; 2021; 12():684807. PubMed ID: 34394080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.